Acute Intermittent Porphyria clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Longitudinal Study of the Porphyrias
open to all eligible people
The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in people with these disorders.
at UCLA UCSF
Our lead scientists for Acute Intermittent Porphyria research studies include Bruce Wang, MD Simon Beaven, MD, PhD.
Last updated: